Drugs / 7-valent pneumococcal-OMPC conjugate vaccine
last change Oct 2003 re-read 3 minutes ago

7-valent pneumococcal-OMPC conjugate vaccine

also known as PncOMPC

Vaccine

Developed for
otitis media · pneumococcal infection
Investigated by
Finnish Institute for Health and Welfare · Merck Sharp & Dohme LLC · Pasteur Merieux Connaught · Wyeth-Lederle Vaccines

Trials 1

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00378417 Mar 1995 → Mar 1999 otitis media, pneumococcal infection Finnish Institute for Health and Welfare Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as 7-valent pneumococcal-OMPC conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00378417 ↗
Known as PncOMPC “To assess the efficacy of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine (PncOMPC) against acute otitis media (AOM), 1666...” PMID 14557958 ↗ Oct 2003
Modality Vaccine “7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine” PMID 14557958 ↗ Oct 2003